KROS PEER ANALYSIS

Keros Therapeutics Inc — metric-by-metric comparison with peers and the industry median

KROSKeros Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

KROSIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	KROS	MSB	TLX	RTALB	Ind. Median
P/E	—	—	—	4.89	17.81
P/B	1.46	—	6.56	0.61●	3.49
EV/EBITDA	—	—	123.31	74.61●	14.92
P/S	12.58	31.91	3.34●	6.67	10.89

Financial Health
Metric	KROS	MSB	TLX	RTALB	Ind. Median
Current Ratio	22.62●	—	1.43	1.21	5.90
Debt/Equity	5.7%	—	112.3%	1.2%●	10.9%
NetDebt/EBITDA	2.99	—	13.13	0.90●	1.15

Profitability
Metric	KROS	MSB	TLX	RTALB	Ind. Median
Net Margin	-256.6%	-115.3%	-0.9%	136.3%●	-125.7%
ROE	-16.8%	-11.3%	-1.8%	15.1%●	-47.5%
ROA	-15.5%	-8.6%	-0.7%	13.1%●	-35.8%
EBITDA Margin	-267.4%	-76.6%	3.0%	9.0%●	-105.8%

Growth + Dividend
Metric	KROS	MSB	TLX	RTALB	Ind. Median
Rev. Growth	-84.5%	410.4%●	56.3%	24.0%	5.1%
NI Growth	—	—	—	134.0%	12.1%
Div. Yield	—	0.0%●	—	0.0%●	0.2%
Payout	—	0.0%	—	0.0%	0.0%

Valuation
Metric	KROS	APLS	CMPX	RCKT	PRLD	NVCT	Ind. Median
P/E	—	3.22	—	—	—	—	17.81
P/B	1.46	1.03●	2.29	1.88	6.84	32.32	3.49
EV/EBITDA	—	2.77	—	—	—	—	14.92
P/S	12.58	0.39●	—	—	24.63	—	10.89

Financial Health
Metric	KROS	APLS	CMPX	RCKT	PRLD	NVCT	Ind. Median
Current Ratio	22.62●	3.63	19.04	6.12	2.03	2.27	5.90
Debt/Equity	5.7%	114.7%	5.3%●	10.4%	29.4%	—	10.9%
NetDebt/EBITDA	2.99	0.38●	2.76	0.62	0.84	—	1.15

Profitability
Metric	KROS	APLS	CMPX	RCKT	PRLD	NVCT	Ind. Median
Net Margin	-256.6%	12.1%●	—	—	-465.3%	—	-125.7%
ROE	-16.8%	46.0%●	-45.9%	-64.4%	-95.2%	-154.4%	-47.5%
ROA	-15.5%	14.1%●	-40.5%	-55.4%	-59.6%	-97.8%	-35.8%
EBITDA Margin	-267.4%	16.3%●	—	—	-455.3%	—	-105.8%

Growth + Dividend
Metric	KROS	APLS	CMPX	RCKT	PRLD	NVCT	Ind. Median
Rev. Growth	-84.5%	42.5%	-100.0%	-100.0%	138.9%●	-100.0%	5.1%
NI Growth	—	—	—	—	—	—	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on KROS

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.